Association [menp]
urinary [qlco]
Albumin [aapp, bacs]
Excretion [phsf]
density [qnco]
Lipoprotein [aapp, bacs]
Heterogeneity [qlco]
Following [tmco]
treatment [ftcn]
Type 2 Diabetes [dsyn]
Patients [podg]
Dipeptidyl Peptidase 4 Inhibitor [phsu]
vildagliptin [orch, phsu]
Pilot Study [resa]
Few [qnco]
Exist [cnce]
Dipeptidyl-Peptidase 4 Inhibitors [phsu]
Affect [menp]
Renal [bpoc]
Interaction [ftcn]
Strong [qlco]
Independent [idcn]
Prognostic Factor [clna]
Cardiovascular disease [dsyn]
diabetic [fndg]
Patients [podg]
Evaluated [ftcn]
effects [qlco]
Dipeptidyl Peptidase 4 Inhibitor [phsu]
Atherogenesis [patf]
Low density lipoprotein [aapp, bacs, lipd]
Heterogeneity [qlco]
Albuminuria [fndg]
diabetics [fndg]
indicator [irda]
Severity [qlco]
Diabetic Nephropathy [dsyn]
Type 2 Diabetes [dsyn]
Patients [podg]
N NOS [aapp, imft]
Controlled [ftcn]
Diabetes Therapy [topp]
treated [topp]
vildagliptin 50 MG [clnd]
weeks [tmco]
Heterogeneity [qlco]
Evaluated [ftcn]
Patients [podg]
Small [qnco]
Dense [qlco]
Small [qnco]
Dense [qlco]
Proportion [qnco]
Small [qnco]
Dense [qlco]
Cholesterol, LDL [bacs, strd]
Albuminuria [fndg]
Evaluated [ftcn]
urinary [qlco]
Albumin/creatinine ratio [lbpr]
weeks [tmco]
treatment [ftcn]
Serum LDL cholesterol level [lbpr]
serum LDL [lbpr]
Small [qnco]
Dense [qlco]
Decreased [qnco]
urinary [qlco]
Albumin/creatinine ratio [lbpr]
Decreased [qnco]
Triglyceride Metabolism [moft]
Marker [clna]
Triglyceride [bacs, lipd]
remnant-like particle cholesterol [aapp, lipd]
Apolipoprotein B [aapp, bacs]
Apo-C [aapp, bacs]
Apo-C [aapp, bacs]
Decreased [qnco]
Delta [inpr]
Absolute Change [idcn]
baseline [bodm]
small value [qlco]
Dense [qlco]
Correlated [qlco]
Delta [inpr]
Triglyceride Metabolism [moft]
Marker [clna]
Delta [inpr]
Haemoglobin A1c [aapp, bacs]
Delta [inpr]
Fasting blood sugar [lbtr]
Regression [patf]
Revealed [qlco]
Delta [inpr]
Small [qnco]
Dense [qlco]
Proportion [qnco]
Delta [inpr]
HbA [aapp, bacs]
Delta [inpr]
Fasting blood sugar [lbtr]
Independent [idcn]
Delta [inpr]
urinary [qlco]
Albumin/creatinine ratio [lbpr]
Beta [plnt]
P NOS [aapp, imft]
Single Arm Study [resa]
treatment [ftcn]
Type 2 Diabetes [dsyn]
vildagliptin [orch, phsu]
PREVENT [phsu]
progression [patf]
Cardiovascular disease [dsyn]
complicating [ftcn]
Diabetes [dsyn]
Improving [qlco]
Heterogeneity [qlco]
Renal function [ortf]
Decreasing [qlco]
Albuminuria [fndg]
randomized controlled trial [inpr, resa]
